Organization | Q-Pharm

Q-Pharm Report issue

For profit Phase 1 Phase 2

Founded: Morristown NJ United States (1994)

Organization Overview

First Clinical Trial

2005

NCT00627679

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Q-Pharma | Q-Pharm Clinics, Royal Brisbane and Women's Hospital | Q-Pharm Phase one unit | Q-Pharm Pty Limited | Q-Pharm Pty Ltd | Q-Pharm Pty Ltd and QIMR Berghofer Medical Research Institute

Active Ingredients

Drugs in Phase 2 Trials (5)

artefenomel (4 trials)

beloranib (3 trials)

dsm265 (2 trials)

mmv390048 (3 trials)

primaquine (1 trial)

Drugs in Phase 1 Trials (13)

Atrosimab (1 trial)

budesonide (rhinocort) (1 trial)

cipargamin (1 trial)

codavax-h1n1 (1 trial)

esomeprazole (nexium) (1 trial)

fp-01.1 (1 trial)

inactivated influenza vaccine (1 trial)

naproxen (naprosyn) (1 trial)

piperaquine (3 trials)

recombinant norovirus hexavalent vaccine (1 trial)

(+)-sj000557733 (1 trial)

sodium chloride (1 trial)

Ziresovir (1 trial)

Drugs in Other Trials (2)

levocarnitine (carnitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Asthma (Phase 1)

Infections (Phase 1)

Influenza, Human (Phase 1)

Malaria (Phase 2)

Malaria, Falciparum (Phase 1)

Obesity (Phase 2)

Respiratory Syncytial Virus Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 23
# of Trial APIs: 20